about
Radioiodine Remnant Ablation: A Critical ReviewManagement Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerProgress in molecular-based management of differentiated thyroid cancer2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerLow vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study.Partial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.Prognostic utility of BRAF mutation in papillary thyroid cancer.Differentiated Thyroid Cancer-Treatment: State of the Art.Clinical significance of observation without repeated radioiodine therapy in differentiated thyroid carcinoma patients with positive surveillance whole-body scans and negative thyroglobulin.Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoterDownregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registriesrhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer: a meta-analysis.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials.Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancerAssociation of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients.Does radioiodine therapy in patients with differentiated thyroid cancer increase the frequency of another malignant neoplasm?Multiple metachronous malignancies, one patient with three primary malignancies.Risk factors for nonsynchronous second primary malignancy and related death in patients with differentiated thyroid carcinoma.Standard and emerging therapies for metastatic differentiated thyroid cancer.Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer.Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis.Use of radioactive iodine for thyroid cancer.Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients.Follicular cell-derived thyroid cancer in children.Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.The potential of proton beam radiation therapy in head and neck cancer.Retrospective imaging study on the diagnosis of pathological false positive iodine-131 scans in patients with thyroid cancer.Challenges of thyroid cancer management in amiodarone-treated patients: a case report.To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysisThe treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma.Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer.The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas
P2860
Q26784202-66D829A0-5A42-4D92-B665-F18AF2647CEEQ26829349-2CF0AFF6-7004-45DA-9EBE-F02D7A1821A6Q26999887-A897C628-FAF6-4DE8-A147-6BF02898FD60Q30367068-0A06F276-40E6-4D3A-A898-2BCA9EBD932DQ33326620-7360DADE-A931-4FA2-8010-FD69FF37F0FCQ33425571-940A0D0B-A47D-4D57-8581-4125972829FDQ33771120-3BAD6324-3C9B-45AF-B2CE-744BCA81E81AQ33839037-F1C08A4B-2D1E-4C0B-B080-C89337D3DD9BQ34385052-358B75F9-6754-439A-95B8-A3E9E7C57577Q34402847-7654C126-D00A-419F-A2CD-8F6966E9819FQ34512455-86FB2320-0453-47AB-9243-79E01B354B30Q34621046-3A698AD7-07C4-4E76-BD59-107028DD60F8Q34914474-1310019C-53FB-4286-ACFE-4541C3B0D971Q34985318-0E46C8D1-C050-407F-B34E-3A98DF34A42EQ35057314-4673AE43-7E86-436B-A383-A13CDBCDD3A3Q35163702-BB10DA15-87B5-4ECE-86D4-3E3CB03F5391Q35201802-A3E8FD69-B6FB-48EE-8AEB-0F2297A855BAQ35213315-F717AE42-3628-4D34-829A-796682DD981DQ35215741-6A6E5FBB-350D-472D-AD0C-993447104783Q35235136-D207153F-C923-43DB-A11F-BE3869583606Q35431483-16666546-3A39-4C01-9E25-208F476C884EQ35528851-876DFC92-6578-41A0-9519-2D35B30F2E85Q35569469-7983D5D4-D59B-43DB-8420-C64B58ECF3B0Q35583906-0E76F452-C382-4B95-B089-E78AB676C02CQ35661353-E9BD1789-5BBC-4BE3-BC30-DEB16E84B934Q35724954-D47BD33B-2413-4CB4-AA8C-3442C495BB29Q35857918-A5D76CEA-8489-447F-A00C-369EEDE5952EQ35961413-41FEA294-C6FB-46C4-A1AB-425C49F183EAQ36038769-14624A1E-3B0F-42A4-820D-F153721087E7Q36085507-913FD40A-899B-4531-8C92-10146FCA52C5Q36266372-9B41F12E-8AE9-450E-9A44-D79107BDEBE8Q36333005-274E5887-EAD2-43FE-97F8-670E13B722B0Q36336560-D66AB3B4-2B42-4EC4-A909-FD1CBD956EB5Q36399019-C8A5FD0E-14DC-451F-8611-1EC78BA58757Q36411194-B27522BB-9EA7-4EA9-BBB8-0A30A9D99696Q36628995-033B9506-05A7-42F1-9AEB-DCB3D1ADEE2CQ36666417-980BE5E0-DEF1-44CE-89BE-957440D6F3D4Q36666691-B7B653C5-4165-431A-AE72-0215449EDDBCQ36789492-545C3A27-791F-42D1-A388-E997ABBA2B45Q36813607-B3D59E48-9E03-4650-BF4C-D51D5DF59404
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Second primary malignancies in thyroid cancer patients.
@ast
Second primary malignancies in thyroid cancer patients.
@en
type
label
Second primary malignancies in thyroid cancer patients.
@ast
Second primary malignancies in thyroid cancer patients.
@en
prefLabel
Second primary malignancies in thyroid cancer patients.
@ast
Second primary malignancies in thyroid cancer patients.
@en
P2093
P2860
P356
P1476
Second primary malignancies in thyroid cancer patients.
@en
P2093
Couette JE
Dottorini ME
Langlois C
Schlumberger M
Schvartz C
de Vathaire F
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601319
P407
P577
2003-11-01T00:00:00Z